世界最新医学信息文摘(电子版)
世界最新醫學信息文摘(電子版)
세계최신의학신식문적(전자판)
World Latest Medicine Information
2013年
21期
20-21
,共2页
131I%甲状腺癌%综合护理
131I%甲狀腺癌%綜閤護理
131I%갑상선암%종합호리
Comprehensive nursing keyword%131I%thyroid cancer
目的:探讨放射性核素131I 治疗分化型甲状腺癌患者的护理。方法选取我科收治的分化型甲状腺癌的患者90例进行分析研究,随机将其分为对照组与观察组,对照组患者实施常规的护理措施,观察组患者实施综合性的护理干预措施,比较两组患者的并发症发生率以及患者满意度。结果观察组患者实施综合性的护理干预措施后并发症的发生率以及患者满意度均明显优于对照组,经比较具有显著差异(P <0.05)。结论对于分化型甲状腺癌的患者实施放射性核素131I 治疗中实施综合性的护理干预措施能够明显的提高临床治疗效果,减少并发症的发生率,并且增加患者治疗的信心与满意度。
目的:探討放射性覈素131I 治療分化型甲狀腺癌患者的護理。方法選取我科收治的分化型甲狀腺癌的患者90例進行分析研究,隨機將其分為對照組與觀察組,對照組患者實施常規的護理措施,觀察組患者實施綜閤性的護理榦預措施,比較兩組患者的併髮癥髮生率以及患者滿意度。結果觀察組患者實施綜閤性的護理榦預措施後併髮癥的髮生率以及患者滿意度均明顯優于對照組,經比較具有顯著差異(P <0.05)。結論對于分化型甲狀腺癌的患者實施放射性覈素131I 治療中實施綜閤性的護理榦預措施能夠明顯的提高臨床治療效果,減少併髮癥的髮生率,併且增加患者治療的信心與滿意度。
목적:탐토방사성핵소131I 치료분화형갑상선암환자적호리。방법선취아과수치적분화형갑상선암적환자90례진행분석연구,수궤장기분위대조조여관찰조,대조조환자실시상규적호리조시,관찰조환자실시종합성적호리간예조시,비교량조환자적병발증발생솔이급환자만의도。결과관찰조환자실시종합성적호리간예조시후병발증적발생솔이급환자만의도균명현우우대조조,경비교구유현저차이(P <0.05)。결론대우분화형갑상선암적환자실시방사성핵소131I 치료중실시종합성적호리간예조시능구명현적제고림상치료효과,감소병발증적발생솔,병차증가환자치료적신심여만의도。
Objective To study the nursing of patients with radionuclide 131I in the treatment of differentiated thyroid carcinoma. Methods 90 cases of patients were chosen in our hospital from differentiated thyroid carcinoma were analyzed, and were randomly divided into control group and observation group, the control group with routine nursing measures, to implement a comprehensive nursing intervention group, compared two groups of patients with disease incidence and patient satisfaction. Results To observe the implementation of comprehensive nursing intervention group patients the incidence of postoperative complications and patient satisfaction were significantly better than the control group, by comparison with significant difference (P < 0.05). Conclusion The comprehensive nursing intervention measures of radionuclide 131I in differentiated thyroid cancer patients can significantly improve the clinical treatment effect, reduce the incidence of complications, and increase the satisfaction and confidence of treatment in patients with.